Table 2. Correlation between the clinicopathologic characteristics and expression of ZEB2 protein in glioma.

			ZEB2(%)
Characteristics		n	High-expression	Low-expression	P
Gender
	Male	53	36(67.9%)	17(32.1%)
	Female	37	23(62.2%)	14(37.8%)	0.571
Age
	≥50	48	32(66.7%)	16(33.3%)
	<50	42	27(64.3%)	15(35.7%)	0.813
WHO Grade
	I	10	4(40.0%)	6(60.0%)
	II	25	14(56.0%)	11(44.0%)
	III	26	18(69.3%)	8(30.7%)
	IV	29	23(79.3%)	6(20.7%)	0.024